Call to action: Harmonization of pharmacovigilance regulations for post‐marketing pregnancy and breastfeeding safety studies

Globally, more than 200 million women become pregnant each year, most of whom receive medications despite limited information on their safe use during pregnancy. The paucity of drug safety data on pregnant and breastfeeding women stems from the routine exclusion of this population from clinical tria...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	British journal of clinical pharmacology 2024-03, Vol.90 (3), p.715-721
Hauptverfasser:	Alexe, Amalia, Eisele, Osa, Fernandes, Maria Fernanda Scantamburlo, Garg, Anju, Kovacs, Birgit, Wurst, Keele, Balramsingh‐Harry, Leesha, Abramova, Nadezda, Zheteyeva, Yenlik, Lewis, David
Format:	Artikel
Sprache:	eng
Schlagworte:	breastfeeding drug safety pharmacovigilance post‐authorisation safety studies pregnancy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!